Barrowclough, C., Haddock, G., Tarrier, N., et al (2001) Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158, 1706–1713.
Cantwell, R. (2003) Substance use and schizophrenia: effects on symptoms, social functioning and service use. British Journal of Psychiatry, 182, 324–329.
Chambers, R. A., Krystal, J. H. & Self, D.W. (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71–83.
Drake, R. E., Mercer-McFadden, C., Mueser, K. T., et al (1998) Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589–608.
Drake, R. E., Essock, S. M., Shaner, A., et al (2001) Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52, 469–476.
Fiander, M., Burns, T., Gregory, J., et al (2003) Assertive community treatment across the Atlantic: comparison of model fidelity in the UK and USA. British Journal of Psychiatry, 182, 248–254.
Gournay, K., Sandford, T., Johnson, S., et al (1997) Dual diagnosis of severe mental health problems and substance abuse/dependence: a major priority for mental health nursing. Journal of Psychiatric Mental Health Nursing, 4, 89–95.
Hassiotis, A., Ukoumunne, O. C., Byford, S., et al (2001) Intellectual functioning and outcome of patients with severe psychotic illness randomised to intensive case management: report from the UK700 trial. British Journal of Psychiatry, 178, 166–171.
Hunt, G. E., Bergen, J. & Bashir, M. (2002) Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research, 54, 253–264.
Laugharne, R., Byford, S., Barber, J. A., et al (2002) The effect of alcohol consumption on cost of care in severe psychotic illness: a report from the UK700 study. Acta Psychiatrica Scandinavica, 106, 241–246.
Ley, A., Jeffery, J. P., McLaren, S., et al (2001) Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Library, Issue 1. Oxford: Update Software.
McCreadie, R. & Kelly, C. (2000) Patients with schizophrenia who smoke: private disaster, public resource. British Journal of Psychiatry, 176, 109.
Ries, R. (1993) Clinical treatment matching models for dually diagnosed patients. Psychiatric Clinics of North America, 16, 167–175.
Scott, H., Johnson, S., Menezes, P., et al (1998) Substance misuse and risk of aggression and offending among the severely mentally ill. British Journal of Psychiatry, 172, 345–350.
Weaver, T., Renton, A., Stimson, G., et al (1999) Severe mental illness and substance misuse comorbidity: research is needed to inform policy and service development. BMJ, 318, 137–138.
Weaver, T., Madden, P., Charles, V., et al (2003a) Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304–313.
Weaver, T., Tyrer, P., Ritchie, J., et al (2003b) Assessing the value of assertive outreach: Qualitative study of process and outcome generation in the UK700 trial. British Journal of Psychiatry, 183, 437–445.